menu
    • menu

    Company profile for DUSA Pharmaceuticals, Inc.

    NEW Drugs in Dev: 3
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    DUSA Pharmaceuticals, Inc.® is a fully integrated specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% photodynamic therapy (PDT) technology platform used in conjunction with it’s proprietary light source, the BLU-U® Blue Light Photodynamic Therapy Illuminator. LEVULAN KERASTICK in combination with the BLU-U is a...
    DUSA Pharmaceuticals, Inc.® is a fully integrated specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% photodynamic therapy (PDT) technology platform used in conjunction with it’s proprietary light source, the BLU-U® Blue Light Photodynamic Therapy Illuminator. LEVULAN KERASTICK in combination with the BLU-U is approved by the U.S. Food and Drug Administration for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp. Actinic Keratosis is the most frequently diagnosed skin disease by U.S. dermatologists. PDT is a two part process in which the target cells are made extremely sensitive to light and then exposed to blue light, which destroys the cells. The BLU-U, as a stand alone device, uses light to treat mild to moderate inflammatory acne. DUSA is based in Wilmington, MA.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    DUSA Pharmaceuticals, Inc.United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    25 Upton Drive Wilmington, MA 01887
    Telephone
    Telephone
    +1 (978) 657-7500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.levulanhcp.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sun Pharma arm settles case with Biofrontera, to get $22.5 million
    Sun Pharma arm settles case with Biofrontera, to get $22.5 million

    02 Dec 2021

    // EXPRESS PHARMA

    https://www.expresspharma.in/sun-pharma-arm-settles-case-with-biofrontera-to-get-22-5-million/

    EXPRESS PHARMA
    02 Dec 2021
    Share Share
    Sun Pharma's subsidiary files patent infringement suit against Biofrontera
    Sun Pharma's subsidiary files patent infringement suit against Biofrontera

    12 Jul 2018

    // Divya Rajagopal ECONOMIC TIMES

    https://health.economictimes.indiatimes.com/news/pharma/sun-pharmas-subsidiary-files-patent-infringement-suit-against-german-drug-maker-biofrontera/64954247

    Divya Rajagopal ECONOMIC TIMES
    12 Jul 2018
    Share Share
    Levulan (Aminolevulinic Acid): DUSA Pharmaceuticals v. Biofrontera
    Levulan (Aminolevulinic Acid): DUSA Pharmaceuticals v. Biofrontera

    23 Mar 2018

    // PATENT LITIGATION

    https://www.pharmacompass.com/pdf/news/levulan-aminolevulinic-acid-dusa-pharmaceuticals-v-biofrontera-1522040614.pdf

    PATENT LITIGATION
    23 Mar 2018
    Share Share

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients

    Details:

    5-aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Skin Neoplasms.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: Phase I/ Phase IIProduct Type: Miscellaneous

    Recipient: Medical Dermatology Specialists

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable April 12, 2017

    blank

    01

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Oncology

    Highest Development Status : Phase I/ Phase II

    Recipient : Medical Dermatology Specialists

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients

    Details : 5-aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Skin Neoplasms.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    April 12, 2017

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in Situ

    Details:

    5-aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Carcinoma, Squamous Cell.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Miscellaneous

    Recipient: Rhode Island Hospital

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable January 19, 2017

    blank

    02

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Oncology

    Highest Development Status : Undisclosed

    Recipient : Rhode Island Hospital

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in Situ

    Details : 5-aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Carcinoma, Squamous Cell.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    January 19, 2017

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

    Details:

    Aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Keratosis, Actinic.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Dermatology Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable January 18, 2017

    blank

    03

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Dermatology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

    Details : Aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Keratosis, Actinic.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    January 18, 2017

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

    Details:

    Aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Keratosis, Actinic.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Dermatology Brand Name: Undisclosed

    Study Phase: Phase IIProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable December 16, 2015

    blank

    04

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Dermatology

    Highest Development Status : Phase II

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK ...

    Details : Aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Keratosis, Actinic.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    December 16, 2015

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)

    Details:

    Aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Keratosis, Actinic.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Dermatology Brand Name: Undisclosed

    Study Phase: Phase IIProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable December 11, 2015

    blank

    05

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Dermatology

    Highest Development Status : Phase II

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)

    Details : Aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Keratosis, Actinic.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    December 11, 2015

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid...

    Details:

    Cetirizine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Keratosis, Actinic.


    Lead Product(s): Cetirizine Dihydrochloride

    Therapeutic Area: Dermatology Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Miscellaneous

    Sponsor: Goldman, Butterwick, Fitzpatrick and Groff

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable May 22, 2015

    blank

    06

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Cetirizine Dihydrochloride

    Therapeutic Area : Dermatology

    Highest Development Status : Undisclosed

    Partner/Sponsor/Collaborator : Goldman, Butterwick, Fitzpatrick and Groff

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse...

    Details : Cetirizine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Keratosis, Actinic.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    May 22, 2015

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis

    Details:

    Aminolevulinic Acid HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Cheilitis.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Dental and Oral Health Brand Name: Undisclosed

    Study Phase: Phase IVProduct Type: Miscellaneous

    Recipient: Dartmouth-Hitchcock Medical Center

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable April 07, 2015

    blank

    07

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Dental and Oral Health

    Highest Development Status : Phase IV

    Recipient : Dartmouth-Hitchcock Medical Center

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis

    Details : Aminolevulinic Acid HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Cheilitis.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    April 07, 2015

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick

    Details:

    Aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Keratosis, Actinic.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Dermatology Brand Name: Undisclosed

    Study Phase: Phase IIProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable November 02, 2014

    blank

    08

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Dermatology

    Highest Development Status : Phase II

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick

    Details : Aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Keratosis, Actinic.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    November 02, 2014

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

    Details:

    Aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Keratosis, Actinic.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Dermatology Brand Name: Undisclosed

    Study Phase: Phase IIProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable September 15, 2014

    blank

    09

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Dermatology

    Highest Development Status : Phase II

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevul...

    Details : Aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Keratosis, Actinic.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    September 15, 2014

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome

    Details:

    5-aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Basal Cell Nevus Syndrome.


    Lead Product(s): Aminolevulinic Acid HCl,Blue Light Photodynamic Therapy

    Therapeutic Area: Rare Diseases and Disorders Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Miscellaneous

    Sponsor: Edward Maytin

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable June 06, 2014

    blank

    10

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl,Blue Light Photodynamic Therapy

    Therapeutic Area : Rare Diseases and Disorders

    Highest Development Status : Undisclosed

    Partner/Sponsor/Collaborator : Edward Maytin

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Synd...

    Details : 5-aminolevulinic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Basal Cell Nevus Syndrome.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    June 06, 2014

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search